The expression of HER-2 in extramammary Paget's disease
Author:
Affiliation:
1. Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto UniversityFaculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)
Reference18 articles.
1. 1. Mazouijian G, Pinkus GS, Haagensen DE Jr. Extramammary Paget's disease – evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembronic antigen, and keratin proteins. Am J Surg pathol. 1984; 8:43-50.
2. 2. Teixeira MR, Kristensen GB, Abeler VM, Heim S. Karyotypic findings in tumors of the vulva and vagina. Cancer Genet Cytogenet. 1999; 111:87-91.
3. 3. Lammie GA, Barnes DM, Millis RR, Gullick WJ. An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease. Histopathology. 1989; 15:505-514.
4. 4. Meissner K, Riviere A, Haupt G, Loning T. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol. 1990; 137:1305-1309.
5. 5. Ogawa T, Nagashima Y, Wada H, Akimoto K, Chiba Y, Nagatani T, Inayama Y, Yao M, Aoki I, Ikezawa Z. Extrammamary Paget's disease: Analysis of growth signal pathway from the hyman epidermal growth factor receptor 2 protein. Human Pathol. 2005; 36:1273-1280.
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13
2. Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma;Frontiers in Oncology;2024-07-09
3. Case report: Disitamab vedotin combined with immunotherapy demonstrated excellent efficacy in scrotal Paget’s disease with Her-2 overexpression;Frontiers in Immunology;2024-06-26
4. A case report of HER 2 positive vulvar extramammary Рaget disease;Clinical Case in Oncology;2024-03-25
5. HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls;Histopathology;2024-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3